Effect of Semaglutide 2.4 mg on Use of Antihypertensive and Lipid-lowering Treatment in STEP Trials

被引：0
|
作者：
Knight, Michael
Adelborg, Kasper
Clements, Jennifer
Iversen, Aske Thorn
Laursen, Peter
Tchang, Beverly
Traina, Andrea
机构：
来源：
OBESITY | 2023年 / 31卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Poster-494
引用
收藏
页码：250 / 250
页数：1
相关论文
共 50 条
  • [1] Effect of semaglutide 2.4 mg on use of antihypertensive and lipid-lowering treatment in five randomized controlled STEP trials
    Tchang, Beverly G.
    Knight, Michael G.
    Adelborg, Kasper
    Clements, Jennifer N.
    Iversen, Aske Thorn
    Traina, Andrea
    OBESITY, 2025, 33 (02) : 267 - 277
  • [2] Effect of semaglutide 2.4 mg on use of antihypertensive and lipidlowering treatment in STEP trials
    Pournaras, Dimitri
    Knight, Michael
    Adelborg, Kasper
    Clements, Jennifer N.
    Iversen, Aske Thorn
    Tchang, Beverly
    Traina, Andrea
    OBESITY SURGERY, 2024, 34 : S7 - S7
  • [3] Combined antihypertensive and lipid-lowering treatment
    Cesari, M
    Pessina, AC
    CURRENT HYPERTENSION REPORTS, 2004, 6 (04) : 300 - 306
  • [4] Combined antihypertensive and lipid-lowering treatment
    Maurizio Cesari
    Achille C. Pessina
    Current Hypertension Reports, 2004, 6 : 300 - 306
  • [5] Semaglutide 2.4 mg for the Treatment of Obesity: Key Elements of the STEP Trials 1 to 5
    Kushner, Robert F.
    Calanna, Salvatore
    Davies, Melanie
    Dicker, Dror
    Garvey, W. Timothy
    Goldman, Bryan
    Lingvay, Ildiko
    Thomsen, Mette
    Wadden, Thomas A.
    Wharton, Sean
    Wilding, John P. H.
    Rubino, Domenica
    OBESITY, 2020, 28 (06) : 1050 - 1061
  • [6] Semaglutide, lipid-lowering drugs, and NAFLD
    Katsiki, Niki
    Athyros, Vasilios G.
    Karagiannis, Asterios
    Mikhailidis, Dimitri P.
    LANCET DIABETES & ENDOCRINOLOGY, 2017, 5 (05): : 329 - +
  • [7] Semaglutide, lipid-lowering drugs, and NAFLD Reply
    Sorli, Christopher
    LANCET DIABETES & ENDOCRINOLOGY, 2017, 5 (05): : 330 - 330
  • [8] The antihypertensive and lipid-lowering treatment to prevent heart attack trial
    Flack, JM
    Nasser, SA
    CURRENT HYPERTENSION REPORTS, 2003, 5 (03) : 189 - 191
  • [9] Antihypertensive, antidiabetic and lipid-lowering treatment frequencies in France in 2010
    Tuppin, Philippe
    Ricci-Renaud, Pauline
    de Peretti, Christine
    Fagot-Campagna, Anne
    Gastaldi-Menager, Christelle
    Danchin, Nicolas
    Alla, Francois
    Allemand, Hubert
    ARCHIVES OF CARDIOVASCULAR DISEASES, 2013, 106 (05) : 274 - 286
  • [10] Lipid-lowering trials in diabetes
    Armitage, J
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 1999, 1 (0M) : M13 - M17
12345